Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy®) in Adult Obese or Overweight Subjects
Clinical trial NCT07150975 · RECRUITING
Trial details
- NCT number
- NCT07150975
- Sponsor
- Gan & Lee Pharmaceuticals.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-23
- Primary completion
- 2027-06-30
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.